Board Member
TerrAscend Corp. (TSNDF)Chief Accounting Officer
Heron Therapeutics, Inc. /De/ (HRTX)Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2026-06-09–present
2024-03-29–present
2023-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, Chief Accounting Officer, Board Member
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $559,803 | $1,630,678 |
| 2024 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $592,250 | $1,536,130 |
| 2023 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | $271,154 | $1,534,873 |
| 2022 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Financial Officer | — | — |
Earnings-call appearances and filed executive appointments or departures, newest first.
